We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$414M
AUM Growth
-$48M
Cap. Flow
-$45M
Cap. Flow %
-10.86%
Top 10 Hldgs %
9.94%
Holding
372
New
102
Increased
39
Reduced
38
Closed
120

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.68M
2
CHKP icon
Check Point Software Technologies
CHKP
+$4.06M
3
CVS icon
CVS Health
CVS
+$3.31M
4
TR icon
Tootsie Roll Industries
TR
+$3.28M
5
APTV icon
Aptiv
APTV
+$3.03M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$4.55M
2
ATEN icon
A10 Networks
ATEN
+$3.81M
3
LULU icon
lululemon athletica
LULU
+$3.74M
4
GLOB icon
Globant
GLOB
+$3.61M
5
B
Barrick Mining
B
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 27.1%
2 Technology 21.13%
3 Consumer Staples 11.41%
4 Consumer Discretionary 10.57%
5 Financials 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
51
ANI Pharmaceuticals
ANIP
$1.88B
$2.49M 0.6%
+31,500
New +$2.73M
ACMR icon
52
ACM Research
ACMR
$5.46B
$2.49M 0.6%
63,000
+10,500
+20% +$391K
ULS icon
53
UL Solutions
ULS
$15.5B
$2.48M 0.6%
+31,500
New +$2.53M
TEM
54
Tempus AI
TEM
$8.32B
$2.48M 0.6%
42,000
+21,000
+100% +$1.64M
TASK icon
55
TaskUs
TASK
$716M
$2.48M 0.6%
+210,000
New +$2.68M
PRAX icon
56
Praxis Precision Medicines
PRAX
$10.3B
$2.48M 0.6%
8,400
-2,100
-20% -$391K
CPRX
57
DELISTED
Catalyst Pharmaceutical
CPRX
$2.45M 0.59%
105,000
-42,000
-29% -$936K
CRMD icon
58
CorMedix
CRMD
$589M
$2.44M 0.59%
210,000
-105,000
-33% -$1.16M
PHAT icon
59
Phathom Pharmaceuticals
PHAT
$679M
$2.44M 0.59%
+147,000
New +$2.1M
RPRX icon
60
Royalty Pharma
RPRX
$25.4B
$2.43M 0.59%
+63,000
New +$2.4M
SLB icon
61
SLB Ltd
SLB
$76.5B
$2.42M 0.58%
63,000
+21,000
+50% +$761K
OZK icon
62
Bank OZK
OZK
$5.63B
$2.42M 0.58%
52,500
+10,500
+25% +$491K
EEFT icon
63
Euronet Worldwide
EEFT
$2.73B
$2.4M 0.58%
31,500
– –
HRMY icon
64
Harmony Biosciences
HRMY
$2.26B
$2.36M 0.57%
63,000
+21,000
+50% +$690K
AGI icon
65
Alamos Gold
AGI
$13B
$2.35M 0.57%
61,000
+10,000
+20% +$348K
ALLE icon
66
Allegion
ALLE
$14.3B
$2.34M 0.57%
+14,700
New +$2.45M
BFH icon
67
Bread Financial
BFH
$4.44B
$2.33M 0.56%
31,500
– –
ARRY icon
68
Array Technologies
ARRY
$809M
$2.32M 0.56%
+252,000
New +$2.16M
GHC icon
69
Graham Holdings Company
GHC
$5.06B
$2.31M 0.56%
+2,100
New +$2.24M
RIGL icon
70
Rigel Pharmaceuticals
RIGL
$733M
$2.25M 0.54%
+52,500
New +$1.98M
CQP icon
71
Cheniere Energy
CQP
$32B
$2.25M 0.54%
42,000
+21,000
+100% +$1.11M
QLYS icon
72
Qualys
QLYS
$6.29B
$2.23M 0.54%
16,800
-8,400
-33% -$1.16M
YOU icon
73
Clear Secure
YOU
$5.46B
$2.21M 0.53%
63,000
+21,000
+50% +$715K
DOLE icon
74
Dole
DOLE
$1.31B
$2.2M 0.53%
147,000
– –
SSNC icon
75
SS&C Technologies
SSNC
$18.7B
$2.2M 0.53%
+25,200
New +$2.15M
1 2
3
4 5

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Hussman Strategic Advisors held 372 positions worth $414M, down 10% from $462M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Hussman Strategic Advisors withdrew a net $45M in Q4 2025, closing 120 positions and reducing 38 holdings. Its most notable exit was TG Therapeutics, an estimated $4.55M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Hussman Strategic Advisors opened a new position in Qualcomm worth $4.67M.

  • Hussman Strategic Advisors's largest Q4 2025 buy was Qualcomm: 27,300 shares worth $4.67M.
  • Hussman Strategic Advisors added most to Ubiquiti in Q4 2025, an estimated $2.66M increase.
  • Hussman Strategic Advisors's biggest Q4 2025 reduction was Barrick Mining, cutting an estimated $3.45M.
  • Hussman Strategic Advisors fully exited TG Therapeutics in Q4 2025, selling an estimated $4.55M.
  • Hussman Strategic Advisors's ten largest holdings make up 9.9% of its $414M portfolio in Q4 2025.
  • Hussman Strategic Advisors opened 102 new positions and closed 120 in Q4 2025.
  • Hussman Strategic Advisors's portfolio value fell 10% quarter-over-quarter to $414M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.